Trial intelligence / Profile preview

Ultrasound-guided cervical medial branch blocks with bupivacaine + steroid versus bupivacaine alone for chronic cervical facet joint pain

TCTR20210301008Phase 3Unknown

Sponsor
Mahidol University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of bupivacaine in Cervical facet joint syndrome, sponsored by Mahidol University. Status: unknown.

02

Drugs

bupivacaine
03

Conditions

Cervical facet joint syndrome

Beyond the preview

Go deeper on TCTR20210301008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20210301008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call